An extension proposal (ENSO) of the EU-funded Open PHACTS project (www.openphacts.org) has been very positively evaluated by a panel of independent experts and has been approved by the IMI Government Board for receiving aditional funding. The strong consensus of the reviewers is that Open PHACTS is a well-run and successful collaborative project that deserves further support. The planned extension program of 18 months (until 2016) will address several new areas including new use cases: (i) target validation and hypothesis generation, (ii) personalised healthcare and (iii) use cases across IMI projects. These new areas are fully supported and are seen to add considerable extra value to the project.
GRIB participates in the Open PHACTS project as coordinator of one of the workpackages.